Cree antidiabetic plant extracts display mechanism-based inactivation of CYP3A4

Author： Tam Teresa W.   Liu Rui   Arnason John T.   Krantis Anthony   Staines William A.   Haddad Pierre S.   Foster Brian C.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.89, Iss.1, 2011-01, pp. : 13-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

By Zhou Shufeng  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 279-304

Adis International

Access to resources Recommend Favorite

Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4

By  

Current Drug Metabolism, Vol. 5, Iss. 5, 2004-01 ,pp. : 415-442

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 990-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Inactivation of CYP3A4 by Benzbromarone in Human Liver Microsomes

By  

Drug Metabolism Letters, Vol. 10, Iss. 1, 2016-03 ,pp. : 16-21

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of Competitive and Mechanism-Based Inhibition by Clarithromycin: Use of Domperidone as a CYP3A Probe-Drug Substrate and Various Enzymatic Sources Including a New Cell-Based Assay with Freshly Isolated Human Hepatocytes

By  

Drug Metabolism Letters, Vol. 4, Iss. 2, 2010-04 ,pp. : 69-76

Bentham Science Publishers

Access to resources Recommend Favorite